Summary of the methodology and results of 21 stimulant growth studies in children
Design: longitudinal from onset of treatment with stimulant | ||||||
---|---|---|---|---|---|---|
Control: untreated children with ADHD or normal children | ||||||
Treatment (mg/day) | n | Δ Height centile | Δ Height z-score | Δ Calculated adult height | Height deficit (cm) | |
Safer and Allen, 19731 | Mph >20 | 10 | p<0.05 (3 years) | 1.0 cm/year* | ||
Mph ⩽20 | 10 | NS | ||||
Dex 12.5 | 29 | p<0.005 (2.9 years) | 1.5 cm/year* | |||
Kalachnik et al, 19823 | Mph 18.4 | 23 boys | NS | |||
Spencer et al, 19924 | Mph 31.4 | 29 | NS | p = 0.023 (1.2 years) | 1.5 at 1.2 years p = 0.035 | |
Lisska and Rivkees, 20035 | Mph 21.6 | 84 | Boys p = 0.01 (3 and 4 years) Girls p = 0.05 (3 years) | Boys 3–4 at 3 years Girls 3–4 at 3 years | ||
MTA Cooperative Group 2001,6 20047 | Mph 34.4 | 222 | 1.05 at 14 months p<0.001 1.92 at 24 months p<0.001 |
Design: longitudinal from onset of treatment with stimulant | ||||||
---|---|---|---|---|---|---|
Control: normative data | ||||||
Treatment (mg/day) | n | Δ Height centile | Δ Height z-score | Height deficit (cm) | ||
Gross 19768 | Mph 34, Dex 16.5 | 84 | NS | |||
Millichap, 19789 | Mph 10–20 | 36 boys | NS | |||
Satterfield et al, 197910 | Mph 24.2 | 72 boys | 1.03 at 1 year p<0.001 0.1 at 2 years NS | |||
Kaffman et al, 197911 | Mph 20, Dex 20 | 50 | NS | |||
Greenhill et al, 198112 | Dex 21 | 13 boys | p<0.025 (1 year) | 1.8 at 1 year p<0.005 | ||
Mattes and Gittelman, 198313 | Mph 41.3 | 56 | p<0.001 (2, 3, 4 years) | 3.3 at 4 years | ||
Gadow et al, 199914 | Mph 30 | 34 | 0.67 at 2 years NS | |||
Poulton and Cowell, 200315 | Mph 27, Dex 13.7 | 51 | p<0.001 (½, 1½ years) | 0.64 at ½year p<0.001 2.33 at 2½years p<0.01 |
Design: longitudinal from onset of treatment with stimulant | ||||||
---|---|---|---|---|---|---|
Control: partially treated children | ||||||
Treatment (mg/day) | n | Δ Height centile | ||||
Quinn and Rapoport 197516 | Mph 20.6 | 23 boys | NS |
Design: longitudinal from onset of treatment with stimulant | ||||||
---|---|---|---|---|---|---|
Control: none | ||||||
Treatment (mg/day) | n | Height velocity | ||||
Sund and Zeiner 200217 | Mph 23.9 Dex 11.9 | 91 boys | NS |
Design: longitudinal study of children changing formulation | ||||||
---|---|---|---|---|---|---|
Control: none | ||||||
Duration of treatment prior to study | Treatment (mg/day) | n | Change in average height of cohort | |||
Wilens et al, 200318 | Not stated (most were treated) | Mph 18–54 | 407 at start 229 at 1 year | NS |
Design: cross sectional | ||||||
---|---|---|---|---|---|---|
Control: untreated children with ADHD or normal children | ||||||
Duration of treatment prior to study | Treatment (mg/day) | n | Height z-score | Height velocity | ||
McNutt et al, 1976,19 197720 | 9–47 months mean 30.3 | Mph 19.8 | 20 | NS | ||
Spencer et al, 1996,21 199822 | Average 4 years follow up | Any treatment ever | 110 boys | p = 0.03 | ||
Mph 38† | 53 boys | NS | ||||
Biederman et al, 200323 | Not stated | Any treatment ever | 87 girls | NS | ||
Mph 28† | 73 girls | NS |
Design: cross sectional | ||||||
---|---|---|---|---|---|---|
Control: normative data | ||||||
Duration of treatment prior to study | Treatment (mg/day) | n | Height centile | Height velocity | ||
n, number of subjects; Mph, methylphenidate daily dose; Dex, dexamphetamine/amphetamine daily dose; NS, method used but did not show statistically significant evidence of attenuated growth. | ||||||
*The height deficits in Safer and Allen’s studies represent averaged annual deficits from children in their first, second, or third year of treatment. | ||||||
†Average dose of methylphenidate or equivalent in subgroup of children who received a stimulant in past 2 years. | ||||||
Millichap and Millichap, 197524 | 1–5 years mean 2½ years | Mph 10–40 | 50 | NS | ||
Vincent et al, 199025 | ½–7 years | Mph 34 | 31 | NS |